(Q38322352)

English

Management of severe acne

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

Europe PubMed Central

Management of severe acne (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

C C Zouboulis

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

V Bettoli

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

language of work or name

0 references

publication date

1 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

172 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

27-36

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Epidemiology of acne vulgaris

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Epidemiology and extracutaneous comorbidities of severe acne in adolescence: a U.S. population-based study

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Genome-wide association study identifies three novel susceptibility loci for severe Acne vulgaris.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

A genome-wide association study of severe teenage acne in European Americans

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

The evidence for the role of transforming growth factor-beta in the formation of abnormal scarring

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Acne as a chronic systemic disease

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Acne-associated syndromes: models for better understanding of acne pathogenesis

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Update and future of systemic acne treatment

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Acne and sebaceous gland function

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

European evidence-based (S3) guidelines for the treatment of acne.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Acne fulminans: report of clinical findings and treatment of twenty-four patients

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

The treatment of acne fulminans: a review of 25 cases

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Systemic antibiotic therapy of acne vulgaris

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Safety of doxycycline and minocycline: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Phototoxic eruptions due to doxycycline--a dose-related phenomenon.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Minocycline in acne vulgaris: benefits and risks.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Oral contraceptive efficacy and antibiotic interaction: a myth debunked

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Azelaic acid: Properties and mode of action

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Hormonal antiandrogens in acne treatment

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Sebocytes are the key regulators of androgen homeostasis in human skin

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Inhibition of 5alpha-reductase activity in SZ95 sebocytes and HaCaT keratinocytes in vitro.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Progestogens with antiandrogenic properties

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon).

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Oral retinoids in the treatment of seborrhoea and acne.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Isotretinoin for acne vulgaris--10 years later: a safe and successful treatment

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Isotretinoin therapy for acne: Results of a multicenter dose-response study

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Oral isotretinoin is as effective as a combination of oral isotretinoin and topical anti-acne agents in nodulocystic acne

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Isotretinoin for the treatment of acne vulgaris: which factors may predict the need for more than one course?

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

The truth behind this undeniable efficacy--recurrence rates and relapse risk factors of acne treatment with oral isotretinoin

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Important controversies associated with isotretinoin therapy for acne

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Depression and Suicidal Behavior in Acne Patients Treated With Isotretinoin: A Systematic Review

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Isotretinoin and risk of inflammatory bowel disease: a French nationwide study

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Ocular side effects possibly associated with isotretinoin usage

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Assessing the availability of the teratogenic drug isotretinoin outside the pregnancy prevention programme: a survey of e-pharmacies.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Comparative pharmacokinetic profiles of a novel isotretinoin formulation (isotretinoin-Lidose) and the innovator isotretinoin formulation: a randomized, 4-treatment, crossover study

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

What is the pathogenesis of acne?

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Enzymes involved in the biosynthesis of leukotriene B4 and prostaglandin E2 are active in sebaceous glands

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

A new concept for acne therapy: a pilot study with zileuton, an oral 5-lipoxygenase inhibitor

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Zileuton, a new efficient and safe systemic anti-acne drug

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Zileuton prevents the activation of the leukotriene pathway and reduces sebaceous lipogenesis.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Neuroimmunoregulation of androgens in the adrenal gland and the skin

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Isotretinoin therapy in acne vulgaris: a 10-year retrospective study in Singapore

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Efficacy of fixed daily 20 mg of isotretinoin in moderate to severe scar prone acne

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin

1 reference

https://api.crossref.org/works/10.1111%2FBJD.13639

21 January 2018

Identifiers

10.1111/BJD.13639

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38322352&oldid=1753505579"